Amprius Technologies, Inc. (AMPX) Financial Statements
Amprius Technologies, Inc. (AMPX) reported trailing twelve-month revenue of $109.2M (up 143.6% year on year) and net income of -$36.5M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$58.4M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
AMPXAmprius Technologies, Inc.Follow AMPX — free
—
Price chart with a free account
- Market cap
- 1.2B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 10 Nov, in 17 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|
| Revenue | 4.4 | 9.1 | 24.2 | 73.0 | 109.2 | |
| Gross profit | -5.7 | -14.7 | -18.3 | 8.3 | 24.3 | |
| Research & development | 2.0 | 3.7 | 7.3 | 9.4 | 13.2 | |
| Operating income | -18.0 | -38.7 | -46.3 | -46.6 | -41.1 | |
| Pre-tax income | -17.3 | -36.8 | -44.7 | -44.0 | -36.5 | |
| Income tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Net income | -17.3 | -36.8 | -44.7 | -44.0 | -36.5 | |
| Diluted EPS ($) | -0.24 | -0.43 | -0.45 | -0.35 | -0.27 | |
| Diluted shares (mn) | 71.3 | 86.2 | 101.9 | 124.6 | — |
USD millions · SEC XBRL
Amprius Technologies, Inc. — questions
- What is Amprius Technologies, Inc.'s revenue?
- $109.2M over the twelve months to 2026-06-30, up 143.6% year on year, from its 10-Q and 10-K filings.
- What is Amprius Technologies, Inc.'s net income?
- -$36.5M over the twelve months to 2026-06-30.
- What is Amprius Technologies, Inc.'s free cash flow?
- -$58.4M over the twelve months to 2026-06-30.
- What are Amprius Technologies, Inc.'s diluted earnings per share?
- $-0.27 over the twelve months to 2026-06-30.
Every figure on this page comes from Amprius Technologies, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.